Cancer survivorship research
St. Jude is identifying the long-term effects of cancer therapy; finding better ways to predict health risks; and helping survivors live longer, healthier lives
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.
Drug discovery & therapeutics
Working closely together, St. Jude scientists and clinicians translate laboratory breakthroughs into novel treatment options for pediatric patients.
Gene therapy at St. Jude
St. Jude is developing innovative gene therapy approaches for patients with blood diseases, immune disorders and other inherited diseases.
Gene therapy cures SCID
Children with "bubble boy" disease are highly susceptible to severe, fatal infections. Learn about a St. Jude study that demonstrates how gene therapy cures SCID.
The genetic roots of cancer
A cancer originates in a child's DNA. Learn how St. Jude is using new technologies to reveal these genetic beginnings and develop cures.
Transcription therapy studies the causes of abnormal gene expression in pediatric leukemias, gliomas, brain cancers, and neurological and immune disorders
Advances in sickle cell disease
Learn how investigators at St. Jude are transforming the way we understand and treat sickle cell disease and other ß-hemoglobinopathies.
Proton therapy arrives at St. Jude
With the first proton therapy center in the world dedicated solely to children, St. Jude combines personalized care with one of the most advanced forms of radiation therapy available to patients.
Spatial transcriptomics are a collection of -omics technologies aimed at visualizing RNA expression profiles within in-tact tissues. Learn more here.